RELMADA THERAPEUTICS, INC. Notes Payable
RELMADA THERAPEUTICS, INC. (RLMD) had Notes Payable of $0 as of 2020-12-31, per its 10-K filed 2021-03-24.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:NotesPayable · last filed 2021-03-24
- 2020-12-31: Notes Payable $0.00.
- 2020-09-30: Notes Payable $0.00.
- 2020-06-30: Notes Payable $0.00.
- 2020-03-31: Notes Payable $0.00.
| Period end | Notes Payable |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-24 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $110.20K 10-K · filed 2021-03-24 |
| 2019-09-30 | $255.90K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $364.20K 10-K · filed 2021-03-24 |
| 2019-03-31 | $28.80K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $114.70K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $200.20K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $285.20K 10-KT · filed 2020-03-26 |
| 2018-03-31 | $27.90K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $111.02K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $194.20K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $276.70K 10-K · filed 2018-09-28 |
| 2017-03-31 | $27.60K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $110.00K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $164.40K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $273.70K 10-K · filed 2017-09-28 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $88.50K 10-Q · filed 2016-02-05 |
| 2015-09-30 | $176.40K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $263.80K 10-K · filed 2016-09-09 |
| 2014-06-30 | $58.40K 10-K · filed 2015-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |